| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |